sentences:
SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021 BackgroundMost of the studies that have informed the public health response to the COVID-19 pandemic in Kenya have relied on samples that are not representative of the general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Systems (HDSSs) to determine the cumulative incidence of infection with SARS-CoV-2.

MethodsWe selected random age-stratified population-based samples at HDSSs in Kisumu, Nairobi and Kilifi, in Kenya. Blood samples were collected from participants between 01 Dec 2020 and 27 May 2021. No participant had received a COVID-19 vaccine. We tested for IgG antibodies to SARS-CoV-2 spike protein using ELISA. Locally-validated assay sensitivity and specificity were 93% (95% CI 88-96%) and 99% (95% CI 98-99.5%), respectively. We adjusted prevalence estimates using classical methods and Bayesian modelling to account for the sampling scheme and assay performance.

ResultsWe recruited 2,559 individuals from the three HDSS sites, median age (IQR) 27 (10-78) years and 52% were female. Seroprevalence at all three sites rose steadily during the study period. In Kisumu, Nairobi and Kilifi, seroprevalences (95% CI) at the beginning of the study were 36.0% (28.2-44.4%), 32.4% (23.1-42.4%), and 14.5% (9.1-21%), and respectively; at the end they were 42.0% (34.7-50.0%), 50.2% (39.7-61.1%), and 24.7% (17.5-32.6%), respectively. Seroprevalence was substantially lower among children (<16 years) than among adults at all three sites (p[≤]0.001).

ConclusionBy May 2021 in three broadly representative populations of unvaccinated individuals in Kenya, seroprevalence of anti-SARS-CoV-2 IgG was 25-50%. There was wide variation in cumulative incidence by location and age.


sentences: Bacterial Pneumonia and Respiratory Culture Utilization among Hospitalized Patients with and without COVID-19 in New York City COVID-19 is associated with prolonged hospitalization and a high risk of intubation, which raises concern for bacterial co-infection and antimicrobial resistance. Previous research has shown a wide range of bacterial pneumonia rates for COVID-19 patients in a variety of clinical and demographic settings, but none have compared hospitalized COVID-19 patients to patients testing negative for SARS-CoV-2 in similar care settings. We performed a retrospective cohort study on hospitalized patients with COVID-19 testing from 10 March 2020 to 31 December 2020. A total of 19,219 patients were included, of which 3,796 tested positive for SARS-CoV-2. We found a 2.6-fold increase (p < 0.001) in respiratory culture ordering in COVID-19 patients. On a per-patient basis, COVID-19 patients were 1.5-fold more likely than non-COVID patients to have abnormal respiratory cultures (46.8% vs. 30.9%, p < 0.001), which was primarily driven by patients requiring intubation. Among patients with pneumonia, a significantly higher proportion of COVID-19 patients had ventilator-associated pneumonia (VAP) relative to non-COVID patients (85.7% vs 55.1%, p <0.001), but a lower proportion had community-acquired (12.2% vs 22.1%, p < 0.01) or hospital-acquired pneumonia (2.1% vs. 22.8%, p < 0.001). There was also a significantly higher proportion of respiratory cultures positive for MRSA, K. pneumoniae, and antibiotic-resistant organisms in COVID-19 patients. Increased rates of respiratory culture ordering for COVID-19 patients therefore appear to be clinically justified for patients requiring intubation, but further research is needed to understand how SARS-CoV-2 increases the risk of VAP.

labels: infectious diseases


sentences:
Cardiovascular Signatures of COVID-19 Predict Mortality and Identify Barrier Stabilizing Therapies STRUCTURED ABSTRACTO_ST_ABSBackgroundC_ST_ABSEndothelial cell (EC) activation, endotheliitis, vascular permeability, and thrombosis have been observed in patients with severe COVID-19, indicating that the vasculature is affected during the acute stages of SARS-CoV-2 infection. It remains unknown whether circulating vascular markers are sufficient to predict clinical outcomes, are unique to COVID-19, and if vascular permeability can be therapeutically targeted.

MethodsEvaluating the prevalence of circulating inflammatory, cardiac and EC activation markers, and the development of a microRNA atlas in 241 patients with suspected SARS-CoV-2 infection, allowed their prognostic value to be assessed by a Random Forest model machine learning approach. Subsequent ex vivo experiments assessed EC permeability responses to patient plasma and were used to uncover modulated gene regulatory networks from which rational therapeutic design was inferred.

FindingsMultiple inflammatory and EC activation biomarkers were associated with mortality in COVID-19 patients and in severity-matched SARS-CoV-2-negative patients, while dysregulation of specific microRNAs at presentation was specific for poor COVID-19-related outcomes and revealed disease-relevant pathways. Integrating the datasets using a machine learning approach further enhanced clinical risk prediction for in-hospital mortality. Exposure of ECs to COVID-19 patient plasma resulted in severity-specific gene expression responses and EC barrier dysfunction which was ameliorated using angiopoietin-1 mimetic or recombinant Slit2-N.

InterpretationIntegration of multi-omics data identified microRNA and vascular biomarkers prognostic of in-hospital mortality in COVID-19 patients and revealed that vascular stabilizing therapies should be explored as a treatment for endothelial dysfunction in COVID-19, and other severe diseases where endothelial dysfunction has a central role in pathogenesis.

RESEARCH IN CONTEXTO_ST_ABSEvidence before this studyC_ST_ABSWhile diagnostic testing has allowed for the rapid identification of COVID-19 cases, the lack of post-diagnosis risk assessment metrics, especially among the highest-risk subgroups, thereby undermined the cascade and allocation of care. To date, the integration of clinical data with broad omics technologies has opened up new avenues for efficiently delineating complex patient phenotypes and their associations with clinical outcomes, with circulating profiles of plasma microRNAs (miRNA), in particular, having been shown to be tightly associated with disease, and capable of providing not only detailed prognostic information but also mechanistic insight.

Added value of this studyMarkers of endothelial dysfunction at presentation, while indicative of poor outcomes in COVID-19-positive patients, likely reflect systemic vascular dysfunction in critically ill patients and are not specific to SARS-CoV-2 infection. More so, the generation of a plasma microRNA atlas uncovers COVID-19-specific prognostic markers and multiple disease-specific pathways of interest, including endothelial barrier dysfunction. Furthermore, synthesis of electronic health record data with clinically relevant multi-omic datasets using a machine learning approach provides substantially better metrics by which mortality can be estimated in patients with severe COVID-19. Finally, targeted stabilization of the endothelial barrier with Q-Peptide and Slit2-N are novel therapeutic avenues that should be explored in COVID-19 patients.

Implications of all the available evidenceTogether, our work provides biological insight into the role of the endothelium in SARS-CoV-2 infection, the importance of miRNA as disease- and pathway-specific biomarkers, and the exciting possibility that endothelial barrier stabilizing treatments might hold promise in COVID-19.

labels: intensive care and critical care medicine


sentences: Monitoring SARS-CoV-2 in wastewater during New York City's second wave of COVID-19: Sewershed-level trends and relationships to publicly available clinical testing data New York Citys ongoing wastewater monitoring program tracked trends in sewershed-level SARS-CoV-2 loads starting in the fall of 2020, just before the start of the Citys second wave of the COVID-19 outbreak. During a five-month study period, from November 8, 2020 to April 11, 2021, viral loads in influent wastewater from each of New York Citys 14 wastewater treatment plants were measured and compared to new laboratory-confirmed COVID-19 cases for the populations in each corresponding sewershed, estimated from publicly available clinical testing data. We found significant positive correlations between viral loads in wastewater and new COVID-19 cases. The strength of the correlations varied depending on the sewershed, with Spearmans rank correlation coefficients ranging between 0.38 and 0.81 (mean = 0.55). Based on a linear regression analysis of a combined data set for New York City, we found that a 1 log10 change in the SARS-CoV-2 viral load in wastewater corresponded to a 0.6 log10 change in the number of new laboratory-confirmed COVID-19 cases/day in a sewershed. An estimated minimum detectable case rate between 2 - 8 cases/day/100,000 people was associated with the method limit of detection in wastewater. This work offers a preliminary assessment of the relationship between wastewater monitoring data and clinical testing data in New York City. While routine monitoring and method optimization continue, information on the development of New York Citys ongoing wastewater monitoring program may provide insights for similar wastewater-based epidemiology efforts in the future.

labels: epidemiology


sentences:
Post-acute sequelae of COVID-19 and adverse psychiatric outcomes: an etiology and risk systematic review protocol IntroductionThe post-acute sequelae of COVID-19 (PASC) is a syndrome characterized by persistent COVID-19 symptoms or the onset of new symptoms following recovery from the initial or acute phase of the illness. Such symptoms often occur four or more weeks after being diagnosed with COVID-19. Although a lot of work has gone into understanding the long-term mental health effects of PASC, many questions related to the etiology and risk of this condition remain. Thus, this protocol is for a systematic review assessing the association between PASC and adverse psychiatric outcomes and whether people with PASC are at greater risk of developing an adverse psychiatric outcome than those without PASC.

Methods and analysisVarious medical databases (e.g., PubMed and EMBASE) will be searched for eligible articles using predefined search criteria. Gray literature will also be explored. Epidemiological observational studies and secondary analyses of randomized controlled trials that report a quantitative relationship between PASC and at least one adverse psychiatric outcome will be included. The Population, Exposure of interest, Comparator, and Outcome (PECO) framework will be used as a standardized framework for the inclusion criteria. The Joanna Briggs Institute (JBI) critical appraisal tools will be used to assess methodological quality and critically appraise the risk of bias in included studies. A random-effects meta-analysis will be conducted if possible. A formal narrative synthesis will be performed if a meta-analysis is impossible due to substantial heterogeneity across studies. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to rate the cumulative certainty of the evidence for all outcomes.

Ethics and DisseminationEthical approval is not required for this study. The study results will be published in a peer-reviewed journal.

Prospero registration numberCRD42022308737

Strengths and limitations of this study{blacksquare} This study documents and addresses etiology, risk factors, and long-term symptoms of COVID-19 among people with post-acute sequelae of COVID-19 (PASC).
{blacksquare}It focuses on a key priority area for new evidence syntheses on the clinical management of COVID-19 and pandemic-related conditions.
{blacksquare}It will include evidence on non-hospitalized and hospitalized patients with a history of PASC.
{blacksquare}Substantial heterogeneity across studies may limit the ability to perform a meta-analysis.
{blacksquare}Findings will inform disease prevention, decision-making, healthcare policy, and clinical research.


sentences:
Community vaccination can shorten the COVID-19 isolation period: an individual-based modeling approach BackgroundIsolation of infected individuals and quarantine of their contacts are usually employed to mitigate the transmission of SARS-CoV-2. While 14-day isolation of infected individuals could effectively reduce the risk of subsequence transmission, it also significantly impacts the patients financial, psychological, and emotional well-being. It is, therefore, vital to investigate how the isolation duration could be shortened when effective vaccines are available and in what circumstances we can live with COVID-19 without isolation and quarantine.

MethodsAn individual-based modeling approach was employed to estimate the likelihood of secondary infections and the likelihood of an outbreak following the isolation of an index case for a range of isolation periods. Our individual-based model integrates the viral loads and infectiousness profiles of vaccinated and unvaccinated infected individuals. The effects of waning vaccine-induced immunity against Delta and Omicron variant transmission were also investigated.

ResultsIn the baseline scenario in which all individuals are unvaccinated, and no nonpharmaceutical interventions are employed, there is a chance of about 3% that an unvaccinated index case will make at least one secondary infection after being isolated for 14 days, and a sustained chain of transmission can occur with a chance of less than 1%. We found that at the outbreak risk equivalent to that of 14-day isolation in the baseline scenario, the isolation duration can be shortened to 7.33 days (95% CI 6.68-7.98) if 75% of people in the community are fully vaccinated during the last three months. In the best-case scenario in which all individuals in the community are fully vaccinated, isolation of infected individuals may no longer be necessary. However, to keep the outbreak risk low, a booster vaccination may be necessary three months after full vaccination. Finally, our simulations showed that the reduced vaccine effectiveness against transmission of the Omicron variant does not much affect the risk of an outbreak if the vaccine effectiveness against infection is maintained at a high level via booster vaccination.

ConclusionsThe isolation duration of a vaccine breakthrough infector could be safely shortened if a majority of people in the community are immune to SARS-CoV-2 infection. A booster vaccination may be necessary three months after full vaccination to keep the outbreak risk low.


sentences:
Both general- and central- obesity are causally associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study IntroductionObesity is observed in a majority of women with polycystic ovarian syndrome (PCOS). Using body mass index (BMI) as a proxy, previous Mendelian randomization studies revealed general obesity potentially causes PCOS. Central obesity frequently demonstrates a stronger association with PCOS, although evidence on its causality is sparse.

ObjectivesTo investigate causal effects of both central- and general- obesity on the development of PCOS via two-sample Mendelian randomization (2SMR).

MethodsSummary GWAS data of female-only, large-sample cohorts of European ancestry were retrieved for anthropometric markers of central obesity (waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR)) and general obesity (BMI and its constituent variables - weight and height), from the IEU Open GWAS Project. As the outcome data, we acquired summary data from a large-sample GWAS (96391 samples; 219 cases and 96172 controls) from the FinnGen cohort. Four 2SMR methods were applied: inverse variance weighted (IVW); MR Egger (MRE); weighted median (WME); weighted mode (WMO). Single SNP-, leave-one-out-, heterogeneity-, horizontal pleiotropy- and outlier- analyses were conducted. Genetic architectures underlying causal associations were explored.

ResultsAll SNPs selected as instrumental variables demonstrated no weak instrument bias (F > 10). Three anthropometric exposures, namely, BMI (OR: 5.55 - 7.24, WC (OR: 6.79 - 24.56), and HC (OR: 6.78 - 24.56), significantly causally associated with PCOS as per IVW, WME, and WMO models. Single SNP- and leave-one-out- sensitivity analysis results were indicative of robust causal estimates. No significant heterogeneity, horizontal pleiotropy, and outliers were observed. We observed a considerable degree of overlap (7 SNPs; 17 genes) across significant causal findings as well as a number of SNPs and genes that were not shared between causal associations.

ConclusionsThis study revealed that both and general- and central obesity potentially cause PCOS. Findings underscore the importance of addressing obesity and adiposity for the prevention and management of PCOS.


sentences:
Heterogeneity of Irritability: Psychometrics of The Irritability and Dysregulation of Emotion Scale (TIDES-13). ObjectiveWe designed The Irritability and Dysregulation of Emotion Scale (TIDES-13) to test whether irritability consisted of several sub-dimensions that would correlate differentially with internalizing/externalizing psychopathology, age, and gender.

MethodParent-report (n = 3935, mean age = 8.9) and youth self-report (n = 579, mean age = 15.1) versions of TIDES-13 were administered to a population-based sample. Exploratory and confirmatory factor analyses were conducted on separate sub-samples. We fit multivariable regression models between TIDES-13 sub-dimensions and age, gender, anxiety, depression, ODD and ADHD trait levels.

ResultsA higher order model with a global irritability dimension and Proneness to Anger, Internalized Negative Emotional Reactivity, Externalized Negative Emotional Reactivity and Reactive Aggression sub-dimensions showed good to excellent fit in both parent-report and self-report. The global irritability dimension had a strong influence on all item variance ({omega}Hierarchical; parent report = .0.94, {omega}Hierarchical; self report = .90). Proneness to Anger, Externalized Negative Emotional Reactivity and Reactive Aggression decreased with age in males, whereas Internal Negative Emotional Reactivity increased with age in females. Internalized Negative Emotional Reactivity was associated with internalizing traits, over and above global irritability. ODD and ADHD were predicted primarily by the global irritability.

ConclusionAlthough irritability can be estimated as an essentially unidimensional construct, differential associations of Internalized Negative Emotional Reactivity with gender and age, and internalizing psychopathology warrant examination in clinical populations. These results support TIDES-13 as a reliable and valid multidimensional measure of irritability and thus may be useful for research and clinical purposes.

labels: psychiatry and clinical psychology


sentences: Robust Determinants of Neurocognitive Development in Children: Evidence from the Pune Maternal Nutrition Study (PMNS) Neurocognitive development is a dynamic process over the life course and is influenced by intrauterine factors as well as later life environment. Using data from the Pune Maternal Nutrition Study (PMNS) from 1994 to 2008, we investigate the association of in-utero, birth, and childhood conditions with offspring neurocognitive development in 686 participants of the cohort, at age 12 years. The life course exposure variables in the analysis include maternal pre-pregnancy size and nutrition during pregnancy, offspring birth measurements, nutrition and physical growth at age 12 years along with parental education and socio-economic status. We used the novel Bayesian Model Averaging (BMA) approach; which has been shown to have better predictive performance over traditional tests of associations. Our study employs 8 standard neurocognitive tests that measure intelligence, working memory, visuo-conceptual and verbal learning, and decision-making/attention at 12 years of age. We control for nutritional-metabolic information based on blood measurements from the pregnant mothers and the children at 12 years of age. Our findings highlight the critical role of parental education and socioeconomic background in determining child neurocognitive performance. Maternal characteristics (pre-pregnancy BMI, fasting insulin during pregnancy) and child height at 12 years were also robust predictors on the BMA. A range of early factors - such as maternal folate and ferritin concentrations during pregnancy, and childs head circumference at birth - remained important determinants of some dimensions of childs neurocognitive development, but their associations were not robust once we account for model uncertainty. Our results suggest that intrauterine influences on long term neurocognitive outcomes may be potentially reversible by post birth remediation. In addition to the current nutritional interventions, public health policy should also consider social interventions in children born into families with low socio-economic status to improve human capital.

labels: public and global health


sentences:
Improving breast cancer diagnostics with artificial intelligence for MRI Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has a very high sensitivity in detecting breast cancer, but it often leads to unnecessary biopsies and patient workup. In this paper, we used an artificial intelligence (AI) system to improve the overall accuracy of breast cancer diagnosis and personalize management of patients undergoing DCE-MRI. On the internal test set (N=3,936 exams), our system achieved an area under the receiver operating characteristic curve (AUROC) of 0.92 (95% CI: 0.92-0.93). In a retrospective reader study, there was no statistically significant difference between 5 board-certified breast radiologists and the AI system (mean {Delta}AUROC +0.04 in favor of the AI system). Radiologists performance improved when their predictions were averaged with AIs predictions (mean {Delta}AUPRC [area under the precision-recall curve] +0.07). Those hybrid predictions also increase interreader agreement (Fleiss kappa {Delta} +0.21 (0.16-0.26)). We demonstrated the generalizability of the AI system using multiple data sets from Poland and the US. In subgroup analysis, we observed consistent results across different cancer subtypes and patient demographics. Using the decision curve analysis, we showed that the AI system can reduce unnecessary biopsies in the range of clinically relevant risk thresholds. This would lead to avoiding benign biopsies in up to 20% of all BI-RADS category 4 patients. Finally, we performed an error analysis, investigating situations where AI predictions were mostly incorrect. This exploratory work creates a foundation for deployment and prospective analysis of AI-based models for breast MRI.

One Sentence SummaryWe developed and evaluated an AI system for predicting breast cancer in MRI that matches the performance of board-certified radiologists and has the potential to prevent unnecessary biopsies.

labels: radiology and imaging


sentences:
A Match Made in Cyberspace: Applicant Perspectives on Virtual Residency Interviews PurposeThe COVID-19 pandemic precipitated an entirely virtual 2020-2021 residency application cycle. As many specialties plan to continue virtual interviews, it is essential to evaluate what aspects worked well and what can be improved.

MethodsFrom April to June 2021, authors surveyed participants of the 2020-2021 Match about their experiences with the virtual application cycle. Survey items asked about benefits and drawbacks of virtual interviews, the utility of social media, and thoughts regarding preference signaling mechanisms and application/interview limits.

ResultsParticipants (n=158) represented 24 states and applied to 31 specialties. The majority (73.1%) were satisfied with their experience during the 2020-2021 Match. Applicants found Twitter (78.4%) and Instagram (69.1%) to be the most helpful social media platforms. Almost all applicants (98.1%) believed that the virtual setting increased financial access to interviews. The majority (68.6%) indicated that residency programs should continue to provide virtual interviews. However, most applicants (73.9%) felt that the virtual setting allowed more students to "hoard" interviews. Many (66.1%) also felt their medical school did not provide adequate electronic equipment for conducting virtual interviews. While many applicants (56.9%) did not support a cap on the number of applications one can submit, most supported a limit on the number of interviews one can attend (62.7%) as well as a mechanism to signal genuine interest in a program (59.7%).

ConclusionsOur study highlights that, across geography and specialty, many applicants would like virtual interviews to continue and offers insight into how medical schools and residency programs can best support applicants in the virtual environment. The virtual setting also provides an opportunity to evaluate mechanisms to address the congestion from the increasingly high number of applications residency programs receive, with most applicants supporting interview caps and preference signaling.

labels: medical education


sentences: The changes in white matter pathways that occur in acute sports-related mild Traumatic Brain Injury Sports-related concussion, a form of mild traumatic brain injury (mTBI), is characterised by transient disturbances of brain function. There is increasing evidence that functional brain changes are driven by subtle abnormalities in white matter microstructure, and diffusion MRI has been instrumental in demonstrating these white matter abnormalities in vivo. However, the reported location and direction of the observed white matter changes in mTBI are quite variable, which is likely attributable to the inherent limitations of the white matter models used. In this cross-sectional study, we apply an advanced and robust technique known as fixel-based analysis to investigate fibre tract-specific abnormalities in professional Australian Football League players with a recent mTBI. We used the fixel-based analysis framework to identify common abnormalities found in specific fibre tracts in participants with an acute mTBI (< 2 weeks after injury; n = 15). We then assessed whether similar changes exist in subacute mTBI (> 2 weeks and < 3 months after injury; n = 15). The control group was 30 neurologically healthy control participants. We assessed microstructural differences in fibre density and fibre bundle morphology and performed whole-brain fixel-based analysis to compare groups. Subsequent tract-of-interest analyses were performed within five selected white matter tracts, to investigate the relationship between the observed tract-specific abnormalities and days since injury, as well as the relationship between these tract-specific changes with cognitive abnormalities. Our whole-brain analyses revealed significant increases in fibre density and bundle cross-section in acute mTBI when compared to controls. Acute mTBI showed even more extensive differences when compared to subacute mTBI than to controls. The fibre structures affected in acute mTBI included the corpus callosum, left prefrontal and left parahippocampal white matter. The fibre density and cross-sectional increases were independent of time since injury in acute mTBI, and were not associated with cognitive deficits. Overall, this study demonstrates that acute mTBI is characterised by specific white matter abnormalities, which are compatible with tract-specific cytotoxic oedema. These oedematous changes were absent in our subacute mTBI participants, although subtle abnormalities may persist in the subacute stage.

labels: neurology


sentences:
Marker genes of incident type 1 diabetes in peripheral blood mononuclear cells of children: A machine learning strategy for large-p, small-n scenarios Background and objectiveType 1 diabetes (TID) is a complex, polygenic disorder, the etiology of which is not fully elucidated. Machine learning (ML) genomics could provide novel insights on disease dynamics while high-dimensionality remains a challenge. This study aimed to identify marker genes of incident T1D in peripheral blood mononuclear cells (PBMC) of children via a ML strategy attuned to high-dimensionality.

MethodsUsing samples from 105 children (81 with incident T1D and 24 healthy controls), we analyzed microarray transcriptomics via a workflow consisting of three sequential steps: application of dimension reduction strategies on the processed transcriptome; ML on the reduced gene expression matrix; and downstream network analyses to demarcate seed nodes (statistically significant genes) and hub genes. Sixteen dimension-reduction algorithms belonging to three groups (3 tailored; 3 regularizations; 10 classic) were applied. Four ML algorithms (multivariate adaptive regression splines, adaptive boosting, random forests, XGB-DART) were trained on the reduced feature set and internally-validated using repeated, 10-fold cross-validation. Marker genes were determined via variable importance metrics. Seed nodes were identified by the  OmicsNet platform while nodes having above average betweenness, closeness, and degree in the network were demarcated as hub genes.

ResultsThe processed gene expression matrix comprised 13515 genes which was reduced to contain 1003 genes collectively selected by dimension reduction algorithms. All four ML algorithms on this reduced feature set attained perfect and uniform predictive performance on internal validation. On removal of redundancies, variable importance metrics identified 30 marker genes of incident T1D in this cohort, while Early Growth Response 2 (EGR2) was uniformly selected by all four ML algorithms as the most important marker gene. Network analyses classified all 30 marker genes as seed nodes. Additionally, we identified 14 hub genes, 7 of which were found to be marker genes of incident T1D elucidated by ML.

ConclusionsWe identified marker genes of incident T1D in PBMC of children via a ML analytic strategy attuned to the high dimensional structure of microarrays, with downstream analyses providing high biological plausibility. The demonstrated ML strategy would be useful in analyzing other high-dimensional biomedical data for biomarker discovery.

labels: genetic and genomic medicine


sentences:
A recombinant BCG-based vaccine against the human respiratory syncytial virus induces a balanced cellular immune response against viral and mycobacterial antigens BACKGROUNDThe human respiratory syncytial virus (hRSV) is a respiratory pathogen responsible for most cases of acute lower respiratory tract infections in infants worldwide. Although this virus represents a significant social and economic burden, there are no safe and effective available vaccines. rBCG-N-hRSV is a vaccine candidate consisting of a recombinant attenuated Mycobacterium bovis Bacillus Calmette-Guerin (BCG) expressing the nucleoprotein of hRSV (N-hRSV).

METHODSrBCG-N-hRSV was applied intradermally in three different doses (5x103, 5x104, or 1x105 CFU) to healthy adults enrolled in a randomized, double-blind, dose-escalating phase 1 clinical trial (NCT03213405). Blood samples were taken before and at various time points after immunization. Cellular and humoral immune parameters were assessed by analyzing circulating immune cells and sera, respectively.

RESULTSPerforin- and Granzyme B-producing PBMCs recognizing viral or mycobacterial antigens were found to increase after immunization with rBCG-N-hRSV. These cells also upregulated IFN-{gamma} and IL-10 secretion in response to N-hRSV and upregulated IFN-{gamma}, IL-6, and TNF- secretion in response to mycobacterial proteins. While naive T cell populations contracted over time, no specific memory T cell subset expanded significantly. Although binding to C1q by anti-N-hRSV or anti-mycobacterial antibodies decreased slightly after immunization, no apparent changes were found in the concentration of IgG subclasses against N-hRSV or mycobacterial antigens.

CONCLUSIONSThe immune response elicited by immunization with rBCG-N-hRSV consists mainly of antigen-specific T cells. The data reported here provide novel information about the characteristics of the immune response elicited after immunization with rBCG-N-hRSV, supporting the safety and immunogenicity of this vaccine.


sentences:
COPD and social distancing in the UK BackgroundThose with Chronic Obstructive Pulmonary Disease (COPD) were at a higher risk of experiencing severe illness in the event of contracting COVID-19. Did they therefore act more cautiously?

AimThe aim was to determine whether the condition of COPD incurred significant change in social distancing behavior compared to the general public.

Design and SettingData was used from the Imperial  COVID-19 Behavioural Tracker, which details results of regular public surveying on attitudes surrounding COVID-19 guidance.

MethodsResponses by U.K. participants to twenty questions reflecting willingness to adhere to social distancing guidance were compared in those reporting COPD and non-COPD status.

ResultsThose with COPD stated a significantly greater willingness to wear face masks during early stages of pandemic. There was greater reluctance to go out and go shopping. There was no apparent or significant difference in willingness to use public transport, suggesting that this was an unavoidable necessity for all. The relationship between level of adherence and COVID-19 case numbers was weak both for those of both COPD and non-COPD status.

DiscussionThese results suggest that those with COPD were more cautious and followed guidance more willingly. Advice provided by GPs and healthcare professionals is likely to be beneficial in guiding patient behaviour.


sentences:
The interaction effect between hemoglobin and hypoxemia on COVID-19 mortality in a sample from Bogota, Colombia: An exploratory study. PurposeWe aimed to assess the effect of hemoglobin (Hb) concentration and oxygenation index on COVID-19 patients mortality risk.

Patients and methodsWe retrospectively reviewed sociodemographic and clinical characteristics, laboratory findings, and clinical outcomes from patients admitted to a tertiary care hospital in Bogota, Colombia. We assessed exploratory associations between oxygenation index and Hb concentration at admission and clinical outcomes. We used a generalized additive model (GAM) to evaluate the nonlinear relations observed and the classification and regression trees (CART) algorithm to assess the interaction effects found.

ResultsFrom March to July 2020, 643 patients were admitted, of which 52% were male. The median age was 60 years old, and the most frequent comorbidity was hypertension (35.76%). The median value of SpO2/FiO2 was 419, and the median Hb concentration was 14.8 g/dL. The mortality was 19.1% (123 patients). Age, sex, and history of hypertension were independently associated with mortality. We described a nonlinear relationship between SpO2/FiO2, Hb concentration and neutrophil-to-lymphocyte ratio with mortality and an interaction effect between SpO2/FiO2 and Hb concentration. Patients with a similar oxygenation index had different mortality likelihoods based upon their Hb at admission. CART showed that patients with SpO2/FiO2 < 324, who were older than 62 years, and had an Hb of [≥] 16 g/dl had the highest mortality risk (96%). Additionally, patients with SpO2/FiO2 > 324 but Hb of < 12 and neutrophil-to-lymphocyte ratio of > 4 had a higher mortality likelihood (57%). In contrast, patients with SpO2/FiO2 > 324 and Hb of > 12 g/dl had the lowest mortality risk (10%).

ConclusionWe found that a decreased SpO2/FiO2 increased mortality risk. Extreme values of Hb, either low or high, showed an increase in likelihood of mortality. However, Hb concentration modified the SpO2/FiO2 effect on mortality; the likelihood of death in patients with low SpO2/FiO2 increased as Hb increased.


sentences:
Post marketing surveillance for Microwave Treatment of Plantar and Common Warts in Adults. A handheld microwave device (Swift(R), Emblation Limited) has been licenced and available for clinical use since 2016 in the fields of podiatry and dermatology and has been extensively used in treating cutaneous warts. As part of post marketing surveillance by the manufacturer, an online 79-item survey was distributed to podiatry clinics in the United Kingdom with a Swift(R) device. A total of 126 clinics responded (59.6%). 6998 adults (<65 years) underwent wart treatment with microwave (81.9% plantar warts; 18.1% common, non-plantar warts). The median efficacy rate was reported as 79.2% (65.9 - 87.5%) and 82.3% (71.4 - 100%) respectively. In older adults (over 65 years) efficacy rates were similar for both sites: plantar (73.2%, 50-90%, n=1232) and non-plantar (80.0%, 42.1-100%, n=276). A median of three treatments was required to bring about resolution. Sub-group analysis of the data revealed good clearance rates in patients with diabetes (79.6%), but less in immunocompromised individuals (61.3%) and those with autoimmune disease (58.6%). Overall, mean user satisfaction was rated as "very satisfied" on a 10-point scale (n=93 practices). A small number of adverse events were reported including blistering, superficial ulceration and poor healing were reported (n=7). Despite the limitations of a post-marketing questionnaire survey, these data provide good evidence of the safety and efficacy for Swift(R) microwave treatment of cutaneous warts.

What is already known about this topic?O_LIMicrowave treatment has shown to be effective in the treatment of cutaneous warts.
C_LI

What does the study add?O_LIThis survey of clinics using SWIFT microwave treatments reports on the effectiveness and safety of the device in the treatment of 8506 adult patients with common and plantar warts.
C_LIO_LIResponding user clinics reporting efficacy with good clearance rates and low levels of adverse events demonstrating microwave is a safe and effective treatment for plantar and common warts.
C_LI

labels: dermatology


sentences:
Distal gene regulation mediated by non-coding RNAs contributes to germline risk for breast and prostate cancer Genome-wide association studies (GWAS) have identified numerous genetic loci associated with breast and prostate cancer risk, suggesting that germline genetic dysregulation influences tumorigenesis. However, the biological function underlying many genetic associations is not well-understood. Previous efforts to annotate loci focused on protein-coding genes (pcGenes) largely ignore non-coding RNAs (ncRNAs) which account for most transcriptional output in human cells and can regulate transcription of both pcGenes and other ncRNAs. Though the biological roles of most ncRNAs are not well-defined, many ncRNAs are involved in cancer development. Here, we explore one regulatory hypothesis: ncRNAs as trans-acting mediators of gene expression regulation in non-cancerous and tumor breast and prostate tissue. Using germline genetics as a causal anchor, we categorize distal (>1 Megabase) expression quantitative trait loci (eQTLs) of pcGenes significantly mediated by local-eQTLs of ncRNAs (within 1 Megabase). We find over 300 mediating ncRNAs and show the linked pcGenes are enriched for immunoregulatory and cellular organization pathways. By integrating eQTL and cancer GWAS results through colocalization and genetically-regulated expression analyses, we detect overlapping signals in nine known breast cancer loci and one known prostate cancer locus, and multiple novel genetic associations. Our results suggest a strong transcriptional impact of ncRNAs in breast and prostate tissue with implications for cancer etiology. More broadly, our framework can be systematically applied to functional genomic features to characterize genetic variants distally regulating transcription through trans-mechanisms.

SIGNIFICANCEThis study identifies non-coding RNAs that potentially regulate gene expression in trans-pathways and overlap with genetic signals for breast and prostate cancer susceptibility, with implications for interpretation of cancer genome-wide association studies.


sentences: Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia The function of senescent-like T cells, transcriptomic features of immune effector senescence (IES) and their influence on therapeutic response were investigated in independent AML clinical cohorts comprising 1,864 patients treated with chemotherapy and/or immune checkpoint blockade (ICB). We show that senescent-like bone marrow CD8+ T cells are impaired in killing autologous AML blasts, and that their proportion negatively correlates with overall survival (OS). We define new IES signatures using two gene expression platforms and report that IES scores correlate with adverse-risk molecular lesions, stemness, and poor outcomes as a potentially more powerful predictor of OS than 2017-ELN risk or LSC17 stemness score. IES expression signatures also identify an ICB- unresponsive tumor microenvironment and predict significantly worse OS in AML as well as in solid tumors. The newly described IES scores provide improved AML risk stratification and could facilitate the delivery of personalized immunotherapies to patients who are most likely to benefit.

labels: hematology


sentences:
Using routine programmatic data to estimate the population-level impacts of HIV self-testing: The example of the ATLAS program in Cote d'Ivoire BackgroundHIV self-testing (HIVST) is recommended by the World Health Organization as an additional HIV testing approach. Since 2019, it has been implemented in Cote dIvoire through the ATLAS project, including primary and secondary distribution channels. While the discreet and flexible nature of HIVST makes it appealing for users, it also makes the monitoring and estimation of the population-level programmatic impact of HIVST programs challenging. We used routinely collected data to estimate the effects of ATLAS HIVST distribution on access to testing, conventional testing (self-testing excluded), diagnoses, and antiretroviral treatment (ART) initiations in Cote dIvoire.

MethodsWe used the ATLAS projects programmatic data between the third quarter (Q) of 2019 (Q3 2019) and Q1 2021, in addition to routine HIV testing services program data obtained from the Presidents Emergency Plan for AIDS Relief dashboard. We performed ecological time series regression using linear mixed models.

FindingsThe results are presented for 1000 HIVST kits distributed through ATLAS. They show a negative but nonsignificant effect of the number of ATLAS HIVST on conventional testing uptake (-190 conventional tests [95% CI: -427 to 37, p=0{middle dot}10]). We estimated that for 1000 additional HIVST distributed through ATLAS, +590 [95% CI: 357 to 821, p<0{middle dot}001] additional individuals have accessed HIV testing, assuming an 80% HIVST utilization rate (UR) and +390 [95% CI: 161 to 625, p<0{middle dot}001] assuming a 60% UR. The statistical relationship between the number of HIVST and HIV diagnoses was significant and positive (+8 diagnosis [95% CI: 0 to 15, p=0{middle dot}044]). No effect was observed on ART initiation (-2 ART initiations [95% CI: -8 to 5, p=0{middle dot}66]).

InterpretationsSocial network-based HIVST distribution had a positive impact on access to HIV testing and diagnoses in Cote dIvoire. This approach offers a promising way for countries to assess the impact of HIVST programs.

FundingUnitaid 2018-23-ATLAS

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed between November 9 and 12, 2021, for studies assessing the impact of HIVST on HIV testing,  conventional testing, HIV diagnoses and ART initiation. We searched published data using the terms "HIV self-testing" and "HIV testing"; "HIV self-testing" and "traditional HIV testing" or "conventional testing"; "HIV self-testing" and "diagnosis" or "positive results"; and "HIV self-testing" and "ART initiation" or "Antiretroviral treatment". Articles with abstracts were reviewed. No time or language restriction was applied. Most studies were individual-based randomized controlled trials involving data collection and some form of HIVST tracking; no studies were conducted at the population level, none were conducted in western Africa and most focused on subgroups of the population or key populations. While most studies found a positive effect of HIVST on HIV testing, evidence was mixed regarding the effect on conventional testing, diagnoses, and ART initiation.

Added value of this studyHIVST can empower individuals by allowing them to choose when, where and whether to test and with whom to share their results and can reach hidden populations who are not accessing existing services. Inherent to HIVST is that there is no automatic tracking of test results and linkages at the individual level. Without systematic and direct feedback to program implementers regarding the use and results of HIVST, it is difficult to estimate the impact of HIVST distribution at the population level. Such estimates are crucial for national AIDS programs. This paper proposed a way to overcome this challenge and used routinely collected programmatic data to indirectly estimate and assess the impacts of HIVST distribution in Cote dIvoire.

Implications of all the available evidenceOur results showed that HIVST increased the overall HIV testing uptake and diagnoses in Cote dIvoire without significantly reducing conventional HIV testing uptake. We demonstrated that routinely collected programmatic data could be used to estimate the effects of HIVST kit distribution outside a trial environment. The methodology used in this paper could be replicated and implemented in different settings and enable more countries to routinely evaluate HIVST programming at the population level.

labels: hiv aids


sentences:
Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infection BackgroundThe diffusion of the SARS-CoV-2 delta (B.1.617.2) variant and the waning of immune response after primary Covid-19 vaccination favoured the breakthrough SARS-CoV-2 infections in vaccinated subjects. To assess the impact of vaccination, we determined the severity of infection in hospitalised patients according to vaccine status.

MethodsWe retrospectively analysed data from patients hospitalised in 10 centres with a SARS-CoV-2 infection (delta variant) from July to November 2021: i) all patients who had completed their primary vaccination at least 14 days before hospital admission; and ii) the same number of completely unvaccinated patients. We assessed the impact of vaccination and other risk factors through logistic regression.

FindingsWe included 955 patients (474 vaccinated and 481 unvaccinated). Vaccinated patients were significantly older, more frequently males, and with more comorbidities. They were less often admitted for Covid-19 (59{middle dot}3% vs. 75{middle dot}1%, p<0{middle dot}001), showed fewer lung lesions, and required oxygen less frequently (57{middle dot}5% vs. 73{middle dot}0%, p<0{middle dot}001), at a lower flow (3{middle dot}0 vs. 6{middle dot}0 L/min, p<0{middle dot}001), and for a shorter duration (3 vs. 6 days, p<0{middle dot}001). They less frequently required intensive care unit admission (16{middle dot}2 % vs. 36{middle dot}0 %, p<0{middle dot}001). Mortality at day 28 was not different between the two groups (16{middle dot}7% vs. 12.2%, p=0{middle dot}075), but multivariate logistic regression showed that vaccination significantly decreased the risk of negative outcomes, including mortality, even when considering older patients, and those with comorbidities.

ConclusionsAmong patients hospitalised with a delta variant SARS-CoV-2 infection, vaccination was associated with less severe forms, even in the presence of comorbidities.


sentences:
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era BackgroundWhile almost 60% of the world has received at least one dose of COVID-19 vaccine, the global distribution of vaccination has not been equitable. Only 4% of the population of low-income countries has received a full primary vaccine series, compared to over 70% of the population of high-income nations.

MethodsWe used economic and epidemiologic models, parameterized with public data on global vaccination and COVID-19 deaths, to estimate the potential benefits of scaling up vaccination programs in low and lower-middle income countries (LIC/LMIC) in 2022 in the context of global spread of the Omicron variant of SARS-CoV2. Outcomes were expressed as number of avertable deaths through vaccination, costs of scale-up, and cost per death averted. We conducted sensitivity analyses over a wide range of parameter estimates to account for uncertainty around key inputs.

FindingsGlobal scale up of vaccination to provide two doses of mRNA vaccine to everyone in LIC/LMIC would cost $35.5 billion and avert 1.3 million deaths from COVID-19, at a cost of $26,900 per death averted. Scaling up vaccination to provide three doses of mRNA vaccine to everyone in LIC/LMIC would cost $61.2 billion and avert 1.5 million deaths from COVID-19 at a cost of $40,800 per death averted. Lower estimated infection fatality ratios, higher cost-per-dose, and lower vaccine effectiveness or uptake lead to higher cost-per-death averted estimates in the analysis.

InterpretationScaling up COVID-19 global vaccination would avert millions of COVID-19 deaths and represents a reasonable investment in the context of the value of a statistical life (VSL). Given the magnitude of expected mortality facing LIC/LMIC without vaccination, this effort should be an urgent priority.


sentences:
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in adult volunteers aged 18-60.

Safety of the vaccine was assessed in 398 volunteers who received two doses of the vaccine (n=298) or placebo (n=100). The studied vaccine has shown good tolerability and safety. No deaths, serious adverse events (AE), or other significant AE related to vaccination have been detected. The most common AE in vaccinated participants was pain at the injection site (p<0.05).

Immunogenicity assessment was performed in 167 volunteers (122 vaccinated and 45 in Placebo Group) separately for the participants who were anti-SARS-CoV-2 nAB negative (69/122 in Vaccine Group and 28/45 in Placebo Group) or positive (53/122 in Vaccine Group and 17/45 in Placebo Group) at screening.

At Day 42 after the first immunization the seroconversion rate in participants who were seronegative at screening was 86.9% with average the geometric mean neutralizing antibody (nAB) titer of 1:20. Statistically significant (p<0.05) increase of IFN-{gamma} production by peptide-stimulated T-cells was observed at Days 14 and 21 after the first immunization.

In participants who were seropositive at screening but had nAB titers below 1:256 the rate of 4-fold increase in nAB levels was 85.2%, while in the participants with nAB titers >1:256 the rate of 4-fold increase in nAB levels was below 45%. For the participants who were seropositive at screening the second immunization did not lead to a significant increase in nAB titers.

In conclusion, inactivated vaccine CoviVac has shown good tolerability and safety, with 86.9% seroconversion rates in participants, who were seronegative at screening. In participants who were seropositive at screening and had nAB titers below 1:256, a single immunization lead to a 4-fold increase in nAB levels in 85.2% cases.


sentences:
Physical behaviours and their association with type 2 diabetes risk in urban South African middle-aged adults: An isotemporal substitution approach IntroductionTo examine the associations between physical behaviours and type 2 diabetes mellitus (T2DM) risk in middle-aged South African men and women.

Research design and methodsThis cross-sectional study included middle-aged men (n=403; age: median [IQR], 53.0 [47.8-58.8] years) and women (n=324; 53.4 [49.1-58.1] years) from Soweto, South Africa. Total movement volume (average movement in milli-g) and time (minutes/day) spent in different physical behaviours, including awake sitting/lying, standing, light intensity physical activity (LPA) and moderate-to-vigorous intensity physical activity (MVPA), were determined by combining the signals from two triaxial accelerometers worn simultaneously on the hip and thigh. All participants completed an oral glucose tolerance test, from which indicators of diabetes risk were derived. Associations between physical behaviours and T2DM risk were adjusted for sociodemographic factors and body composition.

ResultsTotal movement volume was inversely associated with measures of fasting and 2-h glucose and directly associated with insulin sensitivity, basal insulin clearance, beta-cell function, but these associations were not independent of fat mass, except for basal insulin clearance in women. In men, replacing 30 minutes of sitting/lying, standing or LPA with the same amount of MVPA time was associated with 1.2-1.4 mmol/L lower fasting glucose and 12.3-13.4 mgl2/mUmin higher insulin sensitivity. In women, substituting sitting/lying with the same amount of standing time or LPA was associated with 0.5-0.8 mmol/L lower fasting glucose. Substituting 30 minutes sitting/lying with the same amount of standing time was also associated with 3.2 mgl2/mUmin higher insulin sensitivity, and substituting 30 minutes of sitting/lying, standing or LPA with the same amount of MVPA time was associated with 0.25-0.29 ng/mIU higher basal insulin clearance in women.

ConclusionMVPA is important in reducing T2DM risk in men and women but LPA appears to be important in women only. Recommendations for PA may differ by sex.


sentences: Increasing viral transmission paradoxically reduces progression rates to severe COVID-19 during endemic transition Natural infection with SARS-CoV-2 or vaccination induces virus-specific immunity protecting hosts from infection and severe disease. While the infection-preventing immunity gradually declines, the severity-reducing immunity is relatively well preserved. Here, based on the different longevity of these distinct immunities, we develop a mathematical model to estimate courses of endemic transition of COVID-19. Our analysis demonstrates that high viral transmission unexpectedly reduces the rates of progression to severe COVID-19 during the course of endemic transition despite increased numbers of infection cases. Our study also shows that high viral transmission amongst populations with high vaccination coverages paradoxically accelerates the endemic transition of COVID-19 with reduced numbers of severe cases. These results provide critical insights for driving public health policies in the era of  living with COVID-19.


sentences:
Food Insecurity Among Older Adults with a History of Incarceration ObjectivesTo examine the association between history of incarceration (HOI) and food insecurity (FI) among older adults.

MethodsThis is a secondary analysis utilizing data from 12,702 respondents aged 51+ who participated in the 2012 and 2014 waves of The Health and Retirement Study. Multiple logistic regression was used to estimate the association between HOI and FI, adjusting for demographic variables using odds ratios (OR) and 95% confidence intervals (CI).

ResultsIn our sample, 12.8% of participants reported FI. Having a HOI increased odds of FI (OR 1.83; 95% CI 1.52-2.21), especially among Blacks (OR 1.78; 95% CI 1.29-2.46) and Whites (OR 2.27; 95% CI 1.74-2.97), but not Hispanics (OR 1.11; 95% CI 0.69-1.77) or other racial/ethnic groups (OR 1.79; 95% CI 0.71-4.52).

DiscussionFI is an important issue among older adults with a HOI. Stronger linkages between formerly incarcerated older adults and existing food assistance programs are needed.


sentences:
Trajectories of Neurological Recovery 12 Months after Hospitalization for COVID-19: A Prospective Longitudinal Study Background/ObjectivesLittle is known about trajectories of recovery 12-months after hospitalization for severe COVID.

MethodsWe conducted a prospective, longitudinal cohort study of patients with and without neurological complications during index hospitalization for COVID-19 from March 10, 2020-May 20, 2020. Phone follow-up batteries were performed at 6- and 12-months post-COVID symptom onset. The primary 12-month outcome was the modified Rankin Scale (mRS) comparing patients with or without neurological complications using multivariable ordinal analysis. Secondary outcomes included: activities of daily living (Barthel Index), telephone Montreal Cognitive Assessment (t-MoCA) and Neuro-QoL batteries for anxiety, depression, fatigue and sleep. Changes in outcome scores from 6 to 12-months were compared using non-parametric paired-samples sign test.

ResultsTwelve-month follow-up was completed in N=242 patients (median age 65, 64% male, 34% intubated during hospitalization) and N=174 completed both 6- and 12-month follow-up. At 12-months 197/227 (87%) had [≥]1 abnormal metric: mRS>0 (75%), Barthel<100 (64%), t-MoCA[≤]18 (50%), high anxiety (7%), depression (4%), fatigue (9%) and poor sleep (10%). 12-month mRS scores did not differ significantly among those with (N=113) or without (N=129) neurological complications during hospitalization after adjusting for age, sex, race, pre-COVID mRS and intubation status (adjusted OR 1.4, 95% CI0.8-2.5), though those with neurological complications had higher fatigue scores (T-score 47 vs 44, P=0.037). Significant improvements in outcome trajectories from 6- to 12-months were observed in t-MoCA scores (56% improved, median difference 1 point, P=0.002), and Neuro-QoL anxiety scores (45% improved, P=0.003). Non-significant improvements occurred in fatigue, sleep and depression scores in 48%, 48% and 38% of patients, respectively. Barthel and mRS scores remained unchanged between 6 and 12-months in >50% of patients.

DiscussionAt 12-months post-hospitalization for severe COVID, 87% of patients had ongoing abnormalities in functional, cognitive or Neuro-QoL metrics and abnormal cognition persisted in 50% of patients without a prior history of dementia/cognitive abnormality. Only fatigue severity differed significantly between patients with or without neurological complications during index hospitalization. However, significant improvements in cognitive (t-MoCA) and anxiety (Neuro-QoL) scores occurred in 56% and 45% of patients, respectively, between 6- to 12-months. These results may not be generalizable to those with mild/moderate COVID.


sentences:
Factors associated with contraceptive failure in Uganda: Analysis of the 2016 Uganda Demographic and Health Survey IntroductionSustained motivation is essential for effective use of contraceptive methods by women in low- and middle-income countries as many women are likely to abandon use of contraceptives especially when they continually experience episodes of failure. We aimed to determine contraceptive failure rates and associated factors among Ugandan women using data from the 2016 Uganda Demographic Health Survey (UDHS).

MethodsWe analyzed data collected by the UDHS conducted in Uganda 2016. All eligible women aged 15 to 49 years at the time of the survey were enrolled. Discontinuation of contraceptive use due to failure within a 5-year period preceding the survey was the dependent variable.

ResultsA total of 18,505 women were included in this study, 70.8% (n=5153) lived in rural areas while 56.9% (n=5153) owned a mobile phone. The mean age of the women was 29.6years (SD 7.6). The overall prevalence of contraceptive failure was 5.6%, and was higher (7.8%) among women aged 25-29 years or had completed secondary education (7.1%). The odds of contraceptive failure was 38% lower in women who had an informed choice on contraceptives compared to those who didnt [Adjusted Odd ratio, 0.62; 95% confidence interval, 0.50 - 0.77; p< 0.001].

ConclusionThe burden of contraceptive failure among women of reproductive age in Uganda is substantial and significantly varied by socio-demographic characteristics.

labels: obstetrics and gynecology


sentences:
Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease BackgroundUpper respiratory samples for SARS-CoV-2 detection include the gold standard nasopharyngeal (NP) swab, and mid-turbinate (MT) nasal swabs, oropharyngeal (OP) swabs, and saliva. Following the emergence of the omicron (B.1.1.529) variant, limited preliminary data suggest that OP swabs or saliva samples may be more sensitive than nasal swabs, highlighting the need to understand differences in viral load across different sites.

MethodsMT, OP, and saliva samples were collected from symptomatic individuals presenting for evaluation in Atlanta, GA, in January 2022. Longitudinal samples were collected from a family cohort following COVID-19 exposure to describe detection of viral targets over the course of infection.

ResultsSARS-CoV-2 RNA and nucleocapsid antigen measurements demonstrated a nares-predominant phenotype in a familial cohort. A consistent dominant location for SARS-CoV-2 was not found among 54 individuals. Positive percent agreement for virus detection in MT, OP and saliva specimens were 66.7 [54.1-79.2], 82.2 [71.1-93.4], and 72.5 [60.3-84.8] by RT-PCR, respectively, and 46.2 [32.6-59.7], 51.2 [36.2-66.1], and 72.0 [59.6-84.4] by ultrasensitive antigen assay. The composite of positive MT or OP assay was not significantly different than either alone for both RT-PCR and antigen assay (PPA 86.7 [76.7-96.6] and 59.5 [44.7-74.4], respectively).

ConclusionsOur data suggest that SARS-CoV-2 nucleocapsid and RNA exhibited similar kinetics and diagnostic yield in three upper respiratory sample types across the duration of symptomatic disease. Collection of OP or combined nasal and OP samples does not appear to increase sensitivity versus validated nasal sampling for rapid detection of viral antigen.


sentences:
Half the truth is often a great lie: testing for tick-borne diseases and implications for surveillance ImportanceTick-borne diseases (TBD) including Spotted Fever Group Rickettsiosis (SFGR), ehrlichiosis, and increasingly Lyme disease represent a substantial public health concern throughout much of the Southeastern United States. Yet, there is uncertainty about the epidemiology of these diseases due to pitfalls in existing diagnostic test methodologies.

ObjectiveTo examine patterns of diagnostic testing and incidence of TBD in a large, academic healthcare system.

DesignCross-sectional study of diagnostic test results from UNC Health for the period January 1st, 2017 to November 30th, 2020.

SettingLarge, academic healthcare system in central North Carolina including inpatient and outpatient facilities.

ParticipantsAll Individuals seeking routine care at UNC Health facilities who had testing for SFGR, ehrlichiosis or Lyme disease performed during the study period

MeasurementsRates of test positivity, testing completeness, and incidence of TBD

ResultsAmong the 20,528 diagnostic tests performed, we identified 47 laboratory-confirmed, incident cases of SFGR, 27 of ehrlichiosis, and 76 of Lyme, representing incidence rates of 4.7%, 7.1%, and 0.7% respectively. However, 79.3% of SFGR tests and 74.3% Ehrlichia tests lacked a paired convalescent sample. The total number of tests for Lyme disease was more than SFGR and ehrlichiosis combined, despite the relatively low incidence of disease in region. Most striking, testing for ehrlichiosis was performed in only half of patients in whom SFGR was ordered, suggesting that this disease remains underrecognized. Overall, we estimate that there were 187 incident cases of SFGR and 309 of ehrlichiosis that were not identified due to incomplete testing; a number that would drastically increase - and in the case of ehrlichiosis, nearly double - the total number of cases reported.

Conclusions and RelevanceA majority of patients suspected of having TBD did not have testing performed in accordance with established guidelines, substantially limiting our understanding of TBD epidemiology. Furthermore, there appears to be a large discrepancy between the local burden of disease and the testing that is performed. These findings underscore the need to pursue more robust, active surveillance strategies to estimate the burden of TBDs and distribution of causative pathogens.


sentences:
Estimation of COVID-19 cases prevented by vaccination in California ImportanceDespite widespread vaccination against COVID-19 in the United States, there are limited empirical data quantifying the public health impact in the population.

ObjectiveTo estimate the number of cases of COVID-19 averted due to COVID-19 vaccination

Design, Setting, and ParticipantsThe California Department of Public Health (CDPH) provided person-level data on COVID-19 cases and COVID-19 vaccine administration. To estimate the number of COVID-19 cases that would have occurred in the vaccine era in absence of vaccination, we applied a statistical model that estimated the relationship of COVID-19 cases in the pre-vaccine era between the unvaccinated age group (<12 years) and vaccine-eligible groups ([≥]12 years) to COVID-19 case data after the start of vaccination. The primary study outcome was the difference between predicted number of COVID-19 cases in absence of vaccination and observed COVID-19 cases with vaccination. As a sensitivity analysis, we developed a second independent model that estimated the number of vaccine-averted COVID-19 cases by applying published data on vaccine effectiveness to data on COVID-19 vaccine administration and estimated risk of COVID-19 over time.

InterventionCOVID-19 vaccination

Main Outcomes and MeasuresCOVID-19 cases

ResultsThere were 4,585,248 confirmed COVID-19 cases in California from January 1, 2020 to October 16, 2021, during which 27,164,680 vaccine-eligible individuals [≥]12 years were reported to have received at least 1 dose of a COVID-19 vaccine in the vaccine era (79.5% of the eligible population). We estimated that 1,523,500 [95% prediction interval (976,800-2,230,800)] COVID-19 cases were averted and there was a 34% [95% prediction interval (25-43)] reduction in cases due to vaccination in the primary model. Approximately 66% of total cases averted occurred after the delta variant became the dominant strain of SARS-CoV-2 circulating in California. Our alternative model identified comparable findings.

Conclusions and RelevanceThis study provides robust evidence on the public health impact of COVID-19 vaccination in the United States and further supports the urgency for continued vaccination.

Key PointsO_ST_ABSQuestionC_ST_ABSHow many COVID-19 cases have been prevented by COVID-19 vaccination in California?

FindingsIn this empirical analysis of California using data from the Department of Public Health, we estimated that COVID-19 vaccination has prevented over 1.5 million COVID-19 cases from the introduction of vaccination through October 16, 2021.

MeaningThese findings support that COVID-19 vaccination had a large public health impact in California in terms of averted cases of COVID-19 and can be generalized across the United States.


sentences:
Carbapenem resistant Klebsiella pneumoniae infection across the teaching university affiliated hospitals: risk factors for acquisition among hospitalized patients and molecular subtyping BackgroundCarbapenem-resistant Klebsiella pneumoniae (CRKP) is an important healthcare-associated pathogen. This study aimed to identify factors associated with CRKP isolation among hospitalized patients, describe molecular epidemiology, and mortality associated with CRKP isolation.

MethodsWe performed a retrospective case-control study at the two university-affiliated teaching hospitals. 150 patients were included (30 cases and 120 controls) in this study.

Each patient with CRKP, a case-patient, was matched with four controls by admission facility, age, and sex. Controls, patients without CRKP were randomly selected from a computerized list of inpatients whose admission date was the same as that of the case, within 48 hours of the date of the initial positive culture. We calculated the risk of in-hospital death as the number of deaths divided by the number of cases and evaluated the risk of mortality associated with the site of positive culture. Molecular epidemiology investigation using comparison of restricted DNA patterns of CRKP by pulsed-field gel electrophoresis (PFGE) was conducted.

ResultsA greater proportion of cases than controls had undergone an invasive procedure, including use of a central vein catheter (p=0.007, OR, 3.4, 95% CI, 1.4-8.7), and mechanical ventilation (p=0.002, OR, 3.6, 95% CI, 1.6-8.1), nutrition by tube feeding (p=0.001, OR, 4.2, 95% CI, 1.8 -10).

Pre-admission treatment within two months with the following antibiotic classes was associated with CRKP isolation: carbapenems (p=0.001, OR, 24.4, 95% CI, 2.73-217.96), fluoroquinolones (p<0.0001, OR, 6.17, 95% CI, 2.4 - 15.83), anti-pseudomonal penicillin (p = 0.02; OR, 6.03; 95% CI, 1.98 -18.32), and cephalosporins (p=0.001, OR, 5.36, 95% CI, 2.07 -13.87).

The molecular analysis detected that over 90% of isolates shared similar PFGE patterns.

CRKP isolation was associated with significantly higher In-hospital mortality (36.7% vs 3.3%) in comparison to controls (p<.0001).

Positive cultures from sites other than urine were associated with substantially higher mortality than was a positive urine culture (RR= 4.0).


sentences:
A Delphi process to determine clinicians attitudes and beliefs towards paediatric major incident triage within the United Kingdom. IntroductionTriage is a key principle in the effective management of major incidents, yet there is a paucity of evidence surrounding the optimal method of paediatric major incident triage (MIT). This study aimed to derive consensus on key components of paediatric MIT among healthcare professionals involved in the management of paediatric major incidents.

MethodsThis modified two-round online Delphi consensus study, delivered between July and October 2021, included participants from pre-hospital and hospital specialities involved in managing a paediatric major incident. Statements were derived iteratively based on review of MIT tools, and extant literature. A 5-point Likert agreement scale was used to determine consensus, which was set a priori at 70%.

Results111 clinicians completed both rounds, with 13 of 17 statements reaching consensus. Positive consensus was reached on the use of rescue breaths in mechanisms associated with hypoxia or asphyxiation, use of mobility assessment as a crude discriminator of injury, and use of adult physiology for older children. Whilst positive consensus was reached on the benefits of a single MIT tool for use across the entire adult and paediatric age range, there was negative consensus in relation to the clinical implementation of such a tool. Consensus could not be reached regarding the use of a single tool across the whole paediatric age range specifically, nor on the use of rescue breaths in blunt or penetrating trauma.

ConclusionThis Delphi study has established consensus among a large group of subject matter experts on several key elements of paediatric MIT. Further work is required to develop a triage tool that can be implemented based on emerging and ongoing research, and which is acceptable to clinicians.

What this paper adds?O_ST_ABSSection 1: What is already known on this subject?C_ST_ABS{circ} Whilst triage is a key principle in the effective management of a major incident, there is limited evidence surrounding the use of existing paediatric major incident triage (MIT) tools
{circ}Paediatric MIT tools currently used in the UK are associated with high rates of under-triage, failing to identify those in need of life-saving interventions
{circ}Existing paediatric MIT tools differ from adult tools, including approach to physiological ranges, and recommendation for initiation of rescue breaths

Section 2: What this study adds{circ} Consensus was reached supporting use of rescue breaths for mechanisms associated with hypoxia or asphyxiation, mobility as a crude discriminator for serious injury, and adult physiology for older children
{circ}Whilst consensus was reached on benefits related to use of a single tool across all age ranges (adult and paediatric), the expert panel did not support this approach for actual clinical practice
{circ}There was no consensus on use of rescue breaths in blunt or penetrating trauma, or use of a single triage tool for the entire paediatric age group
{circ}Further work is required to develop and implement a MIT tool that accurately identifies children needing life-saving interventions, and that is acceptable to clinicians

labels: emergency medicine


sentences:
Algorithmic Identification of Potentially High Risk Abdominal Presentations (PHRAPs) to the Emergency Department: A Clinically-Oriented Machine Learning Approach BackgroundOlder adults presenting to emergency departments (EDs) with abdominal pain have been shown to be at high risk of subsequent morbidity and mortality. Yet, such presentations are poorly studied in national databases. Claims databases do not record the patients symptoms at the time of presentation to the ED, but rather the diagnosis after testing and evaluation, limiting study of care and outcomes for these high risk abdominal presentations.

ObjectivesWe sought to develop an algorithm to define a patient population with potentially high risk abdominal presentations (PHRAPs) using only variables commonly available in claims data.

Research DesignTrain a machine learning model to predict abdominal pain chief complaints using the National Hospital Ambulatory Medical Care Survey (NHAMCS), a nationally-representative database of abstracted ED medical records.

SubjectsAll patients contained in NHAMCS data from 2013-2018. 2013-2017 were used for predictive modeling and 2018 was used as a hold-out test set.

MeasuresPositive predictive value and sensitivity of the predictive algorithm against a hold-out test set of NHAMCS patients the algorithm was blinded to during training. Predictions were assessed for agreement with either a chief complaint of abdominal pain (contained in "Reason for Visit 1"), or an expanded definition intended to capture visits which were for abdominal concerns. These included secondary or tertiary complaints of abdominal pain or other abdominal conditions, other abdominal-related chief complaint (e.g. nausea or diarrhea, but not pain), discharge diagnosis of an abdominal condition, or reception of an abdominal CT or ultrasound.

ResultsAfter validation on a hold-out data set, a gradient boosting machine (GBM) was the best best-performing machine learning model, but a logistic regression model had similar performance and may be more explainable and useful to future researchers. The GBM predicted a chief complaint of abdominal pain with a positive predictive value of 0.60 (95% CI of 0.56, 0.64) and a sensitivity of 0.29 (95% CI of (0.27, 0.32). Nearly all false positives still exhibited signs of "abdominal concerns" for patients: using the expanded definition of "abdominal concern" the model had a PPV of >0.99 (95% CI of 0.99, 1.00) and sensitivity of 0.12 (95% CI of 0.11, 0.13).

ConclusionThe algorithm we report defines a patient population with abdominal concerns for further study of treatment and outcomes to inform the development of clinical pathways.


sentences: Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence. We critically appraise the literature regarding in-flight transmission of a range of respiratory infections to provide an evidence base for public health policies for contact tracing passengers, given the limited pathogen-specific data for SARS-CoV-2 currently available. Using PubMed, Web of Science, and other databases including preprints, we systematically reviewed evidence of in-flight transmission of infectious respiratory illnesses. A meta-analysis was conducted where total numbers of persons on board a specific flight was known, to calculate a pooled Attack Rate (AR) for a range of pathogens. The quality of the evidence provided was assessed using a bias assessment tool developed for in-flight transmission investigations. We identified 103 publications detailing 165 flight investigations. Overall, 43.7% (72/165) of investigations provided evidence for in-flight transmission. H1N1 influenza A virus had the highest reported pooled attack rate per 100 persons (AR= 1.17), followed by SARS-CoV-2 (AR=0.54) and SARS-CoV (AR = 0.32), Mycobacterium tuberculosis (AR= 0.25), and measles virus (AR= 0.09). There was high heterogeneity in estimates between studies, except for TB. Of the 72 investigations that provided evidence for in-flight transmission, 27 investigations were assessed as having a high level of evidence, 23 as medium, and 22 as low. One third of the investigations that reported on proximity of cases showed transmission occurring beyond the 2x2 seating area. We suggest that for emerging pathogens, in the absence of pathogen-specific evidence, the 2x2 system should not be used for contact tracing. Instead, alternate contact tracing protocols and close contact definitions for enclosed areas, such as the same cabin on an aircraft or other forms of transport, should be considered as part of a whole of journey approach.


sentences: Step forward in epidemiological modeling: Introducing the indicator function to capture waves In the last century mathematical modelled have been used to depict the dynamic spread of infectious. The aim is to determine the total numbers of infectious, recovered and susceptible classes, however the classes only represent accumulative. Having these classes one will be unable to predict waves, to determine a day to day numbers of newly infected cases some additional calculations are required. Collected data from real world situations are represented as day to day newly infections, from these data help to determine numbers of waves. The current existing mathematical models cannot be used to predict waves, while having known the predicted numbers of waves one can take several measures to control the situation. To solve this problem, we questioned the fact that the rates of infection and recovery are constant and suggested an indicator function, the function is obtained using experimental data. The indicator function is used as rate and introduced into the mathematical model. We considered a simple SIR model with different types of differential operators including classical and fractional derivatives. The models were solved numerically using well-known numerical schemes. The numerical solutions were plotted for different theoretical parameters, the obtained results depict real-world behaviours. To test the efficiency of this new approach, we collected data from South Afrca and compared with experimental data. Not only our model waves but also it fit experimental data very accurately. This new approach will open new doors of investigation toward revolution to epidemiological modelling.


sentences:
Sero-prevalence of anti-SARS-CoV-2 antibodies in Chattogram Metropolitan Area, Bangladesh BackgroundSeroprevalence studies of coronavirus disease 2019 (COVID-19) assess the degree of undetected transmission in the community. Different groups, such as healthcare workers (HCWs), garment workers, and others, are deemed vulnerable due to their workplace hazards and immense responsibility.

PurposeThe present study was conducted to estimate the seroprevalence of anti-SARS-CoV-2 antibody (IgG) and its association with different explanatory variables. Further, the antibody was quantified to assess the increasing or decreasing trend over different intervention periods and according to other factors.

MethodologyThis cross-sectional study observed health workers - doctor, nurse, hospital staff, etc. in and outpatients (non-COVID-19) and garments workers of Chattogram metropolitan area (CMA, N=748) from randomly selected six government and private hospitals and two garment factories. Study subjects were included upon written consent, fulfilling specific inclusion criteria. Venous blood was collected following standard aseptic methods. Qualitative and quantitative ELISA was used to identify and quantify antibodies (IgG) in serum samples. Descriptive, univariable, and multivariable statistical analysis was performed.

ResultsOverall seroprevalence was estimated as 66.99% (95% CI: 63.40%-70.40%). Seroprevalence among HCWs, in and outpatients, and garments workers were 68.99 % (95% CI: 63.8%-73.7%), 81.37 % (95% CI: 74.7%-86.7%), and 50.56 % (95% CI: 43.5%-57.5%), respectively. Seroprevalence was 44.47 % (95% CI: 38.6%-50.4%) in the non-vaccinated population while it was significantly (p <0.001) higher in the population receiving the first dose (61.66 %, 95% CI: 54.8%-68.0%) and both (first and second) doses of vaccine (100%, 95% CI: 98.4%-100%). The mean titer of the antibody was estimated as 255.46 DU/ml and 159.08 DU/ml in the population with both doses and one dose of vaccine, respectively, compared to 53.71 DU/ml of the unvaccinated population. A decreasing trend in the titer of antibodies with increasing time after vaccination was observed.

ConclusionsSeroprevalence and mean antibody titer varied according to different factors in this study. The second dose of vaccine significantly increased the seroprevalence and titer, which decreased to a certain level over time. Although antibody was produced following natural infection, the mean titer was relatively low compared to antibody after vaccination. This study emphasizes the role of the vaccine in antibody production. Based on the findings, interventions like continuing extensive mass vaccination of the leftover unvaccinated population and bringing the mass population with a second dose under a third dose campaign might be planned.


sentences:
Use of digital technology tools to characterize patient adherence to prescription-grade omega-3 polyunsaturated fatty acid therapy: Primary results of the DIAPAsOn prospective observational study Background, objectives and methodsDIAPAsOn was a 6-month prospective observational multicenter study in the Russian Federation that examined adherence to a preparation of highly purified omega-3 polyunsaturated fatty acids (OMACOR) in adult patients with a history of recent myocardial infarction or endogenous hypertriglyceridemia. A full description of the studys aims and methods has appeared in JMIR Res Protoc. A feature of DIAPAsOn was the use of a bespoke electronic patient engagement and data collection system.

ResultsThe net average reduction from baseline in both total and low-density lipoprotein cholesterol was approximately 1 mmol/L and the net average increment in high-density lipoprotein cholesterol was 0.2{+/-}0.53 mmol/L. Mean triglyceride levels declined by [~]1.3 mmol/, from an initial level of 2.99{+/-}1.29 mmol/L to 1.67{+/-} 0.67 mmol/L. The percentage of patients with triglyceride <1.7 mmol/L rose from 13.1% at baseline to 54% at study-end.

Digital reporting of adherence was registered by 8.3% of patients (n=180) and average scores indicted poor adherence. However, clinic-based enquiry suggested high levels of adherence.

Data on health-related quality of life accrued from digitally-engaged patients identified improvements among patients reporting high adherence to study treatment, but patient numbers were small.

ConclusionsThe lipid and lipoprotein findings indicate that OMACOR had nominally favorable effects on the blood lipid profile. Less than 10% of patients enrolled in DIAPAsOn used the bespoke digital platform piloted in the study and the level of self-reported adherence to medication by those patients was also low. Reasons for this low uptake and adherence are unclear. Better adherence was recorded by clinical report.

labels: primary care research


sentences:
Associations between antipsychotic use, substance use and relapse risks in patients with schizophrenia - real-world evidence from two national cohorts BackgroundResearch on the effectiveness of pharmacotherapies for schizophrenia-substance use disorder comorbidity (Sch-SUD) is very sparse and non-existent on the prevention of the development of substance use disorders (SUD) in patients with schizophrenia.

AimsTo compare the real-world effectiveness of antipsychotics in schizophrenia in decreasing risks of: 1) development of an initial SUD; and 2) psychiatric hospitalization and hospitalization due to SUD among patients with SUD.

MethodsTwo independent national cohorts including all persons diagnosed with schizophrenia (N=45,476) were followed up for 22 (Finland: 1996-2017) and 11 years (Sweden: 2006-2016). Risks of developing SUD were calculated with between-individual models, and risks of psychiatric and SUD hospitalization with within-individual models using Cox regression and adjusted Hazard Ratios (aHRs) when using vs. not using certain antipsychotics.

ResultsFor schizophrenia patients without SUDs, clozapine use (aHR 0.20, 95%CI 0.16-0.24, p<0.001, in Finland; 0.35, 0.24-0.50, p<0.001, in Sweden) was associated with lowest risks of developing an initial SUD in both countries. Antipsychotic polytherapy was associated with second lowest risk (0.54, 0.44-0.66) in Sweden, and third lowest risk (0.47, 0.42-0.53) in Finland. Risks of psychiatric hospitalization and hospitalization due to SUD were lowest during use of clozapine, antipsychotic polytherapy, and long-acting injectables in both countries. Results were consistent across both countries.

ConclusionClozapine and antipsychotic polytherapy are most strongly associated with reduced chances of developing SUDs among patients with schizophrenia and with lower relapse rates among patients with both diagnoses.


sentences: Phylotyping, Pathotyping and Phenotypic Characteristics of Escherichia coli Isolated from Various Street Foods in Bangladesh The burden of street food contamination remains significantly higher among developing countries, making its consumers health compromised. This study aimed at identifying Escherichia coli in local street foods, track their sources and characterize their virulence properties, antimicrobial susceptibility patterns, and incidence of recent fecal contamination. Twelve E. coli isolates isolated from 28 types of street foods sold at different locations of Dhaka metropolitan city were confirmed by both culture-based and molecular methods. Phylogroup B1 of environment origin was the most predominant (58%, n=12) among the isolates, followed by commensal phylogroup A (16%), phylogroup C (8%), D (8%), and E (8%). Alarmingly, 8% of the isolates were confirmed to be Enteropathogenic E. coli (EPEC), harboring hlyA gene, and 41% were due to recent fecal contamination cases confirmed by the presence of the eae gene. Isolates showed the highest resistance to ampicillin, followed by chloramphenicol. However, resistance could not be correlated to the presence of class 1 integron as isolates sensitive to these antibiotics also harbored this mobile genetic element. The findings of this study demonstrated the presence of antibiotic-resistant, potentially pathogenic E. coli in street food which emphasizes the health hazard associated with consumption of such foods.


sentences:
Worldwide antibiotic resistance dynamics: how different is it from one drug-bug pair to another? BackgroundAntibiotic resistance (ABR) is a major concern for global health. However, factors driving its emergence and dissemination are not fully understood. Identification of such factors is crucial to explain heterogeneity in ABR rates observed across space, time and species and antibiotics.

MethodsWe analyzed count data of resistant isolates from 51 countries over 2006-2019 for nine drug-bug pairs from the surveillance database ATLAS. We characterized ABR spatial and temporal patterns and used a mixed-effect negative binomial model, accounting for country-year dependences with random effects (RE), to investigate associations with potential drivers including antibiotic sales, economic and health indicators, meteorological data, population density and tourism.

FindingsABR patterns were strongly country and drug-bug pair dependent. In 2019, median ABR rates ranged from 6{middle dot}3% for carbapenem-resistant (CR) Klebsiella pneumoniae to 72{middle dot}3% for CR-Acinetobacter baumannii, with heterogeneity across countries (up to 50{middle dot}2% of interquartile range for CR-A. baumannii). Over 2006-2019, carbapenem resistance was on the rise in >75% of investigated countries but no global trend was observed for other resistances. Multivariable analyses identified significant associations of ABR with antibiotic sales, but only in fluoroquinolone-resistant Escherichia coli, CR-A. baumannii and penicillin-resistant Streptococcus pneumoniae; with temperature in investigated Enterobacterales but not in other drug-bug pairs; and with the health system quality for most drug-bug pairs, except in Enterococci and S. pneumoniae. Despite wide consideration of possible explanatory variables, drug-bug pairs still showed high spatial RE variance.

InterpretationThese results reflect the diversity found among human bacterial pathogens and stress the difficulty to generalize global antibiotic resistance findings.

FundingIndependent research Pfizer Global Medical Grant; ANR Labex IBEID (ANR-10-LABX-62)


sentences:
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study ObjectiveTo describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19 survivors with systemic autoimmune rheumatic diseases (SARDs).

MethodsWe surveyed patients with SARDs after confirmed COVID-19 at Mass General Brigham to investigate post-acute sequelae of COVID-19. We obtained data on demographics, clinical characteristics, COVID-19 symptoms/course, and patient-reported measures. We examined baseline predictors of prolonged COVID-19 symptom duration (defined as lasting [≥]28 days) using logistic regression.

ResultsWe analyzed surveys from 174 COVID-19 survivors (mean age 52 years, 81% female, 80% White, 50% rheumatoid arthritis) between March 2021 and January 2022. Fifty-one percent of 127 respondents on any DMARD reported a disruption to their regimen after COVID-19 onset. For individual DMARDs, 56-77% had any change, except for hydroxychloroquine (23%) and rituximab (46%). SARD flare after COVID-19 was reported by 41%. Global patient-reported disease activity was worse at the time of survey than before COVID-19 (mean 6.6{+/-}2.9 vs. 7.6{+/-}2.3, p<0.001). Median time to COVID-19 symptom resolution was 14 days (IQR 9,29). Prolonged symptom duration of [≥]28 days occurred in 45%. Hospitalization for COVID-19 (OR 3.54, 95%CI 1.27-9.87) and initial COVID-19 symptom count (OR 1.38 per symptom, 95%CI 1.17-1.63) were associated with prolonged symptom duration. Respondents experiencing prolonged symptom duration had higher RAPID3 scores (p=0.007) and more pain (p<0.001) and fatigue (p=0.03) compared to those without prolonged symptoms.

ConclusionDMARD disruption, SARD flare, and prolonged symptom duration were common in this prospective study of COVID-19 survivors, suggesting substantial impact on SARDs after acute COVID-19.

labels: rheumatology


sentences:
Assessing agreement between different polygenic risk scores in the UK Biobank 1.1.1 BackgroundPolygenic risk scores (PRS) are proposed to be used in clinical settings for risk stratification, with the public being accustomed to the concept of genetic predisposition to diseases. Much work has focused on developing PRSs for informing people about their risk of future health conditions; however, there are limited investigations on how different PRSs diverge from each other for risk prediction of individuals.

1.2 Methods and FindingsWe compared recently published PRS for three conditions, breast cancer, hypertension and dementia, to assess the stability in practice of running these algorithms for risk prediction in a single large population. We used imputed genotyping data from the UK Biobank (UKB) prospective cohort, limited to the White British subset. We found that

O_LIOnly 65%-79% of SNPs in the first PRS were represented in the more recent PRS for all three diseases, after having taken linkage disequilibrium (LD) into account (R2>0.8).
C_LIO_LIAlthough the difference in the area under the received operator curve (AUC) obtained using the two PRS is hardly appreciable for all three diseases, there were large differences in individual risk prediction between the two PRS.
C_LI

1.3 ConclusionsWe found substantial discordance between different PRS for the same disease, indicating that individuals could receive different medical advice depending on which PRS is used to assess their genetic susceptibility for these disorders. It is desirable to resolving this uncertainty before using PRS for risk stratification in clinical settings.


sentences: Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico There is still a need for safe, efficient and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a live recombinant Newcastle disease virus (NDV) that expresses a stable version of the spike protein in infected cells as well as on the surface of the viral particle (AVX/COVID-12-HEXAPRO, also known as NDV-HXP-S). This vaccine candidate can be grown in embryonated eggs at low cost similar to influenza virus vaccines and it can also be administered intranasally, potentially to induce mucosal immunity. We evaluated this vaccine candidate in prime-boost regimens via intramuscular, intranasal, or intranasal followed by intramuscular routes in an open label non-randomized non-placebo-controlled phase I clinical trial in Mexico in 91 volunteers. The primary objective of the trial was to assess vaccine safety and the secondary objective was to determine the immunogenicity of the different vaccine regimens. In the interim analysis reported here, the vaccine was found to be safe and the higher doses tested were found to be immunogenic when given intramuscularly or intranasally followed by intramuscular administration, providing the basis for further clinical development of the vaccine candidate. The study is registered under ClinicalTrials.gov identifier NCT04871737. Funding was provided by Avimex and CONACYT.


sentences:
Association between Liver Fibrosis and Incident Dementia in the UK Biobank Study BackgroundThere is growing recognition of the role of chronic liver disease in brain health, but the impact of liver fibrosis on dementia risk was unclear. We evaluated the association between liver fibrosis and incident dementia using data from a large prospective cohort study.

MethodsWe performed a cohort analysis using data from the UK Biobank study, which prospectively enrolled approximately 500,000 adults starting 2007 and continues to follow them. Liver fibrosis was defined using validated cutoffs of the Fibrosis-4 (FIB-4) liver fibrosis score. The primary outcome was incident dementia, ascertained using a validated approach based on participants hospital record and mortality data. Secondary outcomes were Alzheimers disease and vascular dementia. We excluded participants with prevalent dementia. We used Cox proportional hazards models to evaluate the association between liver fibrosis and incident dementia while adjusting for potential confounders. In additional models, the FIB-4 score was used as a continuous independent variable. Prespecified interaction analyses tested for effect modification by sex, metabolic syndrome, and apolipoprotein E4 carrier status.

ResultsAmong 455,226 participants included in this analysis, the mean age was 56.5 years and 54% were women. Standard liver chemistries were largely in the normal range. However, 2.17% (95% CI, 2.13-2.22%) had liver fibrosis based on their FIB-4 score. The rate of dementia per 1,000 person-years was 1.76 (95% CI, 1.50-2.07) in participants with liver fibrosis and 0.52 (95% CI, 0.50-0.54) in those without. After adjusting for demographics, socioeconomic deprivation, educational attainment, metabolic syndrome, hypertension, diabetes, dyslipidemia, and tobacco and alcohol use, liver fibrosis was associated with an increased risk of dementia (HR, 1.52; 95% CI, 1.22-1.90). An independent association was also noted between FIB-4, treated as a continuous variable, and dementia (HR per unit, 1.29; 95% CI, 1.20-1.39). Effect modification by sex, metabolic syndrome, and apolipoprotein E4 carrier status was not seen.

ConclusionLiver fibrosis in middle age was associated with an increased risk of incident dementia, independent of metabolic syndrome and shared risk factors. Liver fibrosis may be an underrecognized risk factor for dementia.